2006
DOI: 10.1002/humu.9443
|View full text |Cite
|
Sign up to set email alerts
|

Missense mutation in theN-acetylglucosamine-1-phosphotransferase gene (GNPTA) in a patient with mucolipidosis II induces changes in the size and cellular distribution of GNPTG

Abstract: Mucolipidosis type II (ML II; I-cell disease) and mucolipidosis III (ML III; pseudoHurler polydystrophy) are autosomal recessively inherited disorders caused by a defective Nacetylglucosamine 1-phosphotransferase (phosphotransferase). The formation of mannose 6-phosphate markers in soluble lysosomal enzymes is impeded leading to their increased excretion into the serum, to cellular deficiency of multiple hydrolases, and lysosomal storage of non-digested material. Phosphotransferase deficiency is caused by muta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
27
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 40 publications
(31 citation statements)
references
References 19 publications
4
27
0
Order By: Relevance
“…Mutations in the GNPTAB gene, which encodes the α/β-subunits, are known to be responsible for MLII and MLIIIA [Tiede et al, 2005a and2005b;Kudo et al, 2005;Steet et al, 2005;Paik et al, 2005;Bargal et al, 2006;Tiede et al, 2006;Lam et al, 2007;Otomo et al, 2009]. Mutations in the γ-subunit, encoded by the GNPTG gene (MIM# 607838; chromosome 16p13.3), have been reported to be associated with MLIIIC [Raas-Rothschild et al, 2000Tiede et al, 2004].…”
Section: Introductionmentioning
confidence: 99%
“…Mutations in the GNPTAB gene, which encodes the α/β-subunits, are known to be responsible for MLII and MLIIIA [Tiede et al, 2005a and2005b;Kudo et al, 2005;Steet et al, 2005;Paik et al, 2005;Bargal et al, 2006;Tiede et al, 2006;Lam et al, 2007;Otomo et al, 2009]. Mutations in the γ-subunit, encoded by the GNPTG gene (MIM# 607838; chromosome 16p13.3), have been reported to be associated with MLIIIC [Raas-Rothschild et al, 2000Tiede et al, 2004].…”
Section: Introductionmentioning
confidence: 99%
“…Two homozygous missense mutations, K4Q and K1236M, changing amino acids in the N-and C-terminal domains of the ␣/␤-subunit precursor protein, respectively, have been identified in GNPTAB MLII/III patients (23,24). Here, we show that the K4Q mutation reduced the proteolytic processing of the ␣/␤-subunit precursor protein by 60 -70%, which most likely impaired the 5 LL 6 -dependent ER export rather than directly the proteolytic cleavage in the luminal domain between residues Lys-928-Asp-929.…”
Section: Discussionmentioning
confidence: 99%
“…Because our data excluded 1236 KRK 1238 as active ER export signal, it is unlikely that the K1236M mutation affects the transport of the PT ␣/␤-subunit precursor protein to the Golgi apparatus and subsequently allows its proteolytic cleavage. The intermediate phenotype of a patient who survived to the age of 14 years (24) suggests that the mutant GlcNAc-1-phosphotransferase exhibits residual activity. Further studies are needed to examine whether K1236M substitution impairs the assembly of ␣ 2 ␤ 2 tetramers or ␣ 2 ␤ 2 ␥ 2 hexamer complexes in the ER, which might be important for proper phosphorylation of all lysosomal hydrolases (7).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…in premature translational termination and mRNA decay (p.V176GfsX18, p.G204VfsX17, or p.Q203HfsX3), lead to the loss of the M6P recognition marker on lysosomal enzymes (24,39). 6 In addition mutations in GNPTAB encoding the ␣/␤-subunit precursor result in a secondary degradation of the ␥-subunit (40,41) and the associated loss of the M6P marker. Whereas proteolytic modifications of the ␤-subunit can be excluded in macrophages, no data are available on the ␣-subunit polypeptide because specific antibodies are lacking.…”
Section: Discussionmentioning
confidence: 99%